These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18431656)

  • 1. Preformulation considerations for controlled release dosage forms. Part II. Selected candidate support.
    Chrzanowski F
    AAPS PharmSciTech; 2008; 9(2):639-45. PubMed ID: 18431656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
    Shete H; Patravale V
    Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microenvironmental pH modulation in solid dosage forms.
    Badawy SI; Hussain MA
    J Pharm Sci; 2007 May; 96(5):948-59. PubMed ID: 17455349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preformulation considerations for controlled release dosage forms. Part I. Selecting candidates.
    Chrzanowski F
    AAPS PharmSciTech; 2008; 9(2):635-8. PubMed ID: 18431655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preformulation considerations for controlled release dosage forms. Part III. Candidate form selection using numerical weighting and scoring.
    Chrzanowski F
    AAPS PharmSciTech; 2008; 9(2):646-50. PubMed ID: 18500562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salt formation improved the properties of a candidate drug during early formulation development.
    Sigfridsson K; Ahlqvist M; Lindsjö M; Paulsson S
    Eur J Pharm Sci; 2018 Jul; 120():162-171. PubMed ID: 29730322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
    Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracking of crystalline-amorphous transition of carvedilol in rotary spun microfibers and their formulation to orodispersible tablets for in vitro dissolution enhancement.
    Szabó P; Sebe I; Stiedl B; Kállai-Szabó B; Zelkó R
    J Pharm Biomed Anal; 2015 Nov; 115():359-67. PubMed ID: 26280924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of nicergoline polymorphs crystallized in several organic solvents.
    Malaj L; Censi R; Capsoni D; Pellegrino L; Bini M; Ferrari S; Gobetto R; Massarotti V; Di Martino P
    J Pharm Sci; 2011 Jul; 100(7):2610-22. PubMed ID: 21254066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
    Bellur Atici E; Karlığa B
    J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms.
    Tiţa B; Fuliaş A; Bandur G; Marian E; Tiţa D
    J Pharm Biomed Anal; 2011 Sep; 56(2):221-7. PubMed ID: 21665404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride.
    Bansal S; Beg S; Asthana A; Garg B; Asthana GS; Kapil R; Singh B
    Drug Deliv; 2016; 23(2):437-51. PubMed ID: 24865292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The manufacture and characterisation of hot-melt extruded enteric tablets.
    Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
    Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T; Sandhu HK; Talele TT; Serajuddin AT
    Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miniaturized approach for excipient selection during the development of oral solid dosage form.
    Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
    J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of two-drug controlled release non-biodegradable microparticles for potential treatment of muscles pain and spasm and their simultaneous spectrophotometeric estimation.
    Khan SA; Ahmad M; Murtaza G; Aamir MN; Akhtar N; Kousar R
    Acta Pol Pharm; 2010; 67(3):299-306. PubMed ID: 20524433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tannate complexes of antihistaminic drug: sustained release and taste masking approaches.
    Rahman Z; Zidan AS; Berendt RT; Khan MA
    Int J Pharm; 2012 Jan; 422(1-2):91-100. PubMed ID: 22037447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogels based on interpenetrating network of chitosan and polyvinyl pyrrolidone for pH-sensitive delivery of repaglinide.
    Vaghani SS; Patel MM
    Curr Drug Discov Technol; 2011 Jun; 8(2):126-35. PubMed ID: 21513486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.